Fund Holdings — Aisling Capital Management LP

Total Portfolio Value:
$335.24M
Total Bought:
$0
Total Sold:
$828.7K
Net Transaction:
-$828.7K
Notable People:
Andrew Newman Schiff, Steven Arnote Elms, Aisling Capital Partners Iv Llc
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
BridgeBio Pharma, Inc.(BBIO)6,068,1256,068,1250$160.02M$244.97M73.07%+$84.95M
Verona Pharma plc (VRNA)ADS1,115,3521,115,3520$18.18M$22.17M6.61%+$3.99M
Syndax Pharmaceuticals, Inc.(SNDX)1,025,0001,025,0000$14.88M$22.15M6.61%+$7.27M
Biomea Fusion, Inc.(BMEA)798,757798,7570$10.99M$11.60M3.46%+$607.1K
COMPASS Pathways plcADS(CMPS)964,500964,5000$7.14M$8.44M2.52%+$1.30M
Monte Rosa Therapeutics, Inc.(GLUE)1,472,3311,472,3310$7.05M$8.32M2.48%+$1.27M
Nuvation Bio Inc.CL A(NUVB)2,541,0092,541,0090$3.40M$3.84M1.14%+$432.0K
Spruce Biosciences, Inc. (SPRB)1,205,5111,205,5110$2.72M$3.53M1.05%+$807.7K
Poseida Therapeutics Inc. (PSTX)1,043,2671,043,2670$2.48M$3.51M1.05%+$1.02M
Marker Therapeutics, Inc.(MRKR)314,286314,2860$1.43M$1.73M0.52%+$301.7K
Elevation Oncology Inc (ELEV)2,834,9102,834,9100$1.88M$1.52M0.45%-$356.1K
Reneo Pharmaceuticals Inc (RPHM)886,075886,0750$6.74M$1.42M0.42%-$5.33M
Avrobio, Inc. (AVRO)1,009,7791,009,7790$1.56M$1.37M0.41%-$181.8K
Aclaris Therapeutics, Inc.(ACRS)434,455434,4550$2.98M$456.2K0.14%-$2.52M
Viracta Therapeutics Inc (VIRX)288,571288,5710$300.1K$164.5K0.05%-$135.6K
Atreca Inc. (BCEL)CL A387,653387,6530$101.2K$51.2K0.02%-$50.0K
Aeglea Biotherapeutics Inc (AGLE)COM NEW(SYRE)67,6450-67,645$828.7K$0—-$828.7K
Page 1 of 1
Aisling Capital Management LP — 13F Holdings — Q4 2023 | TickerTrail